Fortrea Holdings Inc. is a global contract research organization (CRO), which provides clinical development solutions to the life sciences industry. The Company is engaged in providing biopharmaceutical product and medical device development services to pharmaceutical, biotechnology and medical device customers. The Company offers customers flexible delivery models that include full service, functional service provider, and hybrid service structures. It provides phase I-IV clinical trial management, clinical pharmacology and consulting services. The Company manages its business through a single segment, Clinical Services, that provides services across the clinical pharmacology and clinical development spectrum. The Company has access to all key markets worldwide through a footprint of primary office locations in five countries (the United States, the United Kingdom, China, India and Singapore) with field operations in other jurisdictions worldwide.

• Revenue in USD (TTM)2.77bn
• Net income in USD-233.60m
• Incorporated2023
• Employees15.50k

• Location
  Fortrea Holdings Inc8 Moore DriveDURHAM 27709United StatesUSA
• Fax+1 (302) 636-5454
• Websitehttps://www.fortrea.com/